1 / 7

US & China Asthma and COPD Drugs Market

TMRu2019s US & China Asthma and COPD Drugs Market market report helps analyze trends and significant developments in the industry. In addition, it also provides insights predicting growth rates of the US & China Asthma and COPD Drugs Market market using detailed assessment of key drivers, threats, restraints, along with opportunities that are likely to open doors for growth in coming years. <br><br>For More Technical Insights, Download Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15857

pharmahealth
Download Presentation

US & China Asthma and COPD Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved US & China Asthma and COPD Drugs Market Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. . ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved U.S. and China Asthma and COPD Drugs Market: Snapshot  The U.S. and China market for asthma and chronic obstructive pulmonary disease (COPD) drugs is expected to exhibit growth at a steady pace in the next few years. Factors such as a significant rise prevalence of COPD and asthma in these two countries, advancements in diagnostic methods, and rising awareness among patients regarding the available treatment methods are considered key to the overall growth of the market over the period 2016–2024.  The market is expected to exhibit growth at a moderate pace in the first few years of the forecast period, chiefly owing to the patent expiries of leading drugs and the subsequent price erosion. However, the market is expected to witness new drug candidates by 2020, which will help the market tread along a better growth path in the forthcoming years.  Transparency Market Research estimates that the market will exhibit a 4.1% CAGR from 2016 through 2024, rising to a valuation of US$18.7 bn by 2024 from US$13.0 bn in 2015.

  3. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 U.S. and China Asthma and COPD Drugs Market Analysis and Forecast, By Drug Class Chapter 6 U.S. and China Asthma and COPD Drugs Market Analysis and Forecast, By Indication Chapter 7 U.S. and China Asthma and COPD Drugs Market Analysis and Forecast, By Region Chapter 8 U.S. Asthma and COPD Drugs Market Analysis and Forecast Chapter 9 China Asthma and COPD Drugs Market Analysis and Forecast Chapter 10 Competition Landscape Access Full TOC

  5. ©2019 Transparency Market Research, All Rights Reserved Report Highlights: • Transparency Market Research estimates that the US & China Asthma and COPD Drugs Market will exhibit a 4.1% CAGR from 2016 through 2024, rising to a valuation of US$18.7 bn by 2024 from US$13.0 bn in 2015 • Some of the leading vendors presently operating in the U.S. and China asthma and COPD drugs market profiled in the report are Boehringer Ingelheim, GlaxoSmithKline plc, Merck and Co., Inc., Novartis AG, AstraZeneca plc, and F. Hoffmann-La Roche. Request Sample of Report ©2019 Transparency Market Research, All Rights Reserved

  6. ©2019 Transparency Market Research, All Rights Reserved About Us Transparency Market Research (TMR) is a market intelligence company, providing North America business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR Syndicated Research report covers a different sector—such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods, and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified research methodology, our syndicated reports strive to serve clients and satisfy their overall research requirement.

  7. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related